Article
2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 Deficiency.
Journal of clinical immunology - 23 Nov 2024
Brakta Charlyne, Tabet Anne-Claude, Puel Mathilde, Pacault Mathilde, Stolzenberg Marie-Claude, Goudet Claire, Merger Marguerite, Reumaux Héloïse, Lambert Nathalie, Alioua Najiba, Malan Valérie, Hanein Sylvain, Dupin-Deguine Delphine, Treiner Emmanuel, Lefèvre Guillaume, Farhat Méryem-Maud, Luca Luminita Elena, Hureaux Marguerite, Li Hailun, Chelloug Nora, Dehak Rabha, Boussion Simon, Ouachée-Chardin Marie, Schleinitz Nicolas, Abou Chahla Wadih, Barlogis Vincent, Vély Frédéric, Oksenhendler Eric, Quartier Pierre, Pasquet Marlène, Suarez Felipe, Bustamante Jacinta, Neven Bénédicte, Picard Capucine, Rieux-Laucat Frédéric, Lévy Jonathan, Rosain Jérémie
Abstract excerpt
PURPOSE: CTLA4 deficiency is an inborn error of immunity (IEI) due to heterozygosity for germline loss-of-function variants of the CTLA4 gene located on chromosome 2q33.2. CTLA4 deficiency underlies pleiotropic immune and lymphoproliferation-mediated features with incomplete penetrance. It has been identified in hundreds of patients but copy number variants (CNVs) have been reported in only 12 kindreds, including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
